© 2021 BioMarin. All rights reserved.
| Recent Price | $87.58 |
|---|---|
| 52 Week High | $92.57 |
| 52 Week Low | $71.59 |
| Average Volume (30 days) | 1.74M |
| Beta | 0.52 |
| Market Cap | $15.84B |
|---|---|
| Shares Outstanding | 183.59M |
| Float | 142.43M |
| Yield % | -- |
|---|---|
| Annual Dividend | -- |
| Payout Ratio | -- |
| Quick Ratio (MRQ) | 2.8 |
|---|---|
| Current Ratio (MRQ) | 4.5 |
| LT Debt/Capital (MRQ) | 20% |
| Total Debt/Equity (MRQ) | 25% |
| Price/Earnings (TTM) | 862.90 |
|---|---|
| Price/Sales (TTM) | 8.57 |
| Price/Book (MRQ) | 3.71 |
| Price/Cash Flow (TTM) | 56.20 |
| Earnings (TTM) | $0.10 |
|---|---|
| Sales (TTM) | $10.07 |
| Book Value (MRQ) | $23.24 |
| Cash Flow (TTM) | $1.53 |
| Cash (MRQ) | $5.89 |
| Return on Equity (TTM) | 0.4% |
|---|---|
| Return on Assets (TTM) | 0.3% |
| Return on Investment (TTM) | 0.4% |
| Gross Margin (TTM) | 74.0% |
|---|---|
| EBIT Margin (TTM) | -1.8% |
| Profit Margin (TTM) | -1.1% |